Skip to main content
European Statements on Hospital Pharmacy
Menu
Home
About
From the President
Background
What is Hospital Pharmacy ?
Implementation Plan
Implementation Ambassadors
Success timeline
Milestones
Who Supports the Statements?
Support Us
Statements
The European Statements of Hospital Pharmacy
Development
Final Statements
Stakeholders
Information for Stakeholders
Patients
What do Statements mean for the Patient?
Statements Directory
Who Supports the Statements?
Doctors
What do the Statements mean for Doctors?
Statements Directory
Who Supports the Statements?
Nurses
What do the Statements mean for the Nurses and Midwives?
Statements Directory
Who Supports the Statements?
Other Healtcare Professionals
What do the Statements mean for other Healthcare Professionals?
Statements Directory
Who Supports the Statements?
Hospital Managers
What do the Statements mean for Hospital Managers?
Statements Directory
Who Supports the Statements?
Policy Makers
What do the Statements mean for Policy Makers?
Statements Directory
Who Supports the Statements?
Regulators and Insurers
What do the Statements mean for Regulators and Insurers?
Statements Directory
Who supports the statements?
Accrediting Organisations
What does the Statements mean for Accrediting Organisations?
Statements Directory
Who Supports the Statements?
Education Providers
What do the Statements mean for Education Providers?
Statements Directory
Who Supports the Statements?
Technology Providers
What do the Statements mean for the Technology Providers?
Statements Directory
Who Supports the Statements?
Pharmaceutical Industry
What do the Statements mean for the Pharma?
Statements Directory
Who Supports the Statements?
Pharmacy Profession
What do the Statements mean for the Pharmacy profession?
Statements Directory
Who Supports the Statements?
Let us know what you need
Evidence Map
GPI
Statement Implementation Learning Collaborative Centres (SILCC)
Case studies
Why are Case Studies Important ?
Self-assessment
Self-assessment tool
Development
Assess your hospital pharmacy
SILCC
Statement Implementation Learning Collaborative Centres
Apply for the SILCC programme
Map of SILCC Hosts
Surveys
2016 EAHP Statements Survey
Statements Survey 2015
2015 Baseline Survey
Resources
News
News
Statement Implementation Newsletter
Ambassadors Profiles
Media
Photo Galleries
Video Galleries
You are here
Home
»
Evidence Map
Evidence map
Type
GPI
SILCC
Case Study
Fulltext search
Keywords
- Any -
Acceptance rate
Accident and emergency
Accident and emergency Management
Active ingredient Quality
Administration Drug dispensing
Admission
Admission Clinical pharmacy
Adverse drug events
Allergy Patient safety
Antimicrobial stewardship
Antiretroviral therapy
Au
Automated production
Budget impact
Business case
Cancer
Chemotherapy
Children Quality
Clinical Pharmacy
Clinical Pharmacy services
Clinical pharmacy services Education and research
Clinical pharmacy services IT
Clinical pharmacy›Clinical pharmacy services Drug prescribing and dosing
Clinical practice
Clinical trial medication
Clinical trials Clinical pharmacy
Co-medication Drug safety
Competency assessment
Computer assisted prescribing (cpoe)
Computerised medical record
Contracts Procurement and market access
Cost control
Cost saving
Cytostatic preparations
Databases
Databases Management
Discharge
Discharge managemen
Discharge management
Discharge prescription
Dispensing drugs
Dispensing Patient safety
Distance learning
Dose banding
Drug administration
Drug and therapeutic committee
Drug dispensing
Drug dispensing›Robotic dispensing system Management
Drug distribution and supply
Drug formulary management
Drug formulation
Drug group
Drug information
Drug interaction
Drug prescribing and dosing
Drug prescribing and dosing›Prescription compliance Quality
Drug prescribing pattern Quality
Drug procurement
Drug reconciliation
Drug safety
Drug safety Patient safety
Drug selection
Drug shortage
Drug shortage Procurement and market access
Drug stability
Drug therapy outcomes
Drug use evaluation
Drug use evaluation›Cost analysis Drug use evaluation
Education
Education and research
Education Therapeutic areas
Educational program
Educational tools Management
Electronic communication
Electronic communication Management
Electronic communications
Electronic medication record
Electronic prescribing system
Error-avoiding strategies
Error-avoiding strategies Patient safety
Error-avoiding strategy
Errors
Errors Quality
Forecasting
Guidelines
Guidelines impact Quality
Health economics
Health information
Health information management
Healthcare team
High risk medication
Hiv & aids
Hospital pharmacy competencies
Hospital setting
Human resource management
Icu
Improvement action
Information transmission
Interventions Clinical pharmacy
IT
L01 - cytostatic
Labelling Preparation and compounding
Lean
Look-alike
management
Market access
Medication erro
Medication error
Medication error Drug safety
Medication reconciliation
Medication review
Medication review Clinical pharmacy
Medication-use system
Medicine prices
Medicines optimisation
Multidisciplinary Hospital setting
Multidisciplinary team
National standards
Oncology
Oncology pharmacy
Optimisation of therapy
Organisation of health services
Organisational development
Outpatient
Patient characteristics
Patient discharge
Patient feedback
Patient information
Patient information Education and research
Patient involvement
Patient perspectives
Patient safet
Patient safety
Pharmaceutical care
Pharmaceutical care Drug information
Pharmaceutical counselling
Pharmacist prescribing
Pharmacovigilance system
Pharmacy intervention Management
Pharmacy interventions
Pharmacy interventions (pi)
Preparation
Preparation and compounding
Prescribing error
Prescribing errors Preparation and compounding
Prescription appropriateness
Process improvement
Procurement and market access
Procurement and market acess
Product information
project management
Project management Quality
QC/QA
Quality
Quality control
Quality improvementi
Quality research
Ready to use Hospital setting
Reconciliation Education and research
Rheumatology
Risk minimisation
Risk minimization
S01 - ophthalmologicals Drug selection
Safety profile
Seamless care
Secondary care
Selection of drugs
Shared decision making
Simulation Patient safety
Sound-alike
Sterile production
Stock control
Storage conditions
Storage systems
Suppliers
Suppliers Drug distribution and supply
Supply chain
Supply chain Drug selection
Technology implementation
Tender
Therapeutic areas
Theraputic areas
Training
Training IT
Training Management
Unit-dose drug distribution
›Education
›Patient safety
›Storage systems
Country
- Any -
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo (Brazzaville)
Congo (Kinshasa)
Cook Islands
Costa Rica
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Honduras
Hong Kong S.A.R., China
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao S.A.R., China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
North Korea
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Vatican
Venezuela
Vietnam
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Statement
- Any -
Statement 1.1
Statement 1.2
Statement 1.3
Statement 1.4
Statement 1.5
Statement 1.6
Statement 1.7
Statement 2.1
Statement 2.2
Statement 2.3
Statement 2.4
Statement 2.5
Statement 2.6
Statement 2.7
Statement 3.1
Statement 3.2
Statement 3.3
Statement 3.4
Statement 3.5
Statement 3.6
Statement 4.1
Statement 4.2
Statement 4.3
Statement 4.4
Statement 4.5
Statement 4.6
Statement 4.7
Statement 4.8
Statement 5.1
Statement 5.10
Statement 5.11
Statement 5.2
Statement 5.3
Statement 5.4
Statement 5.5
Statement 5.6
Statement 5.7
Statement 5.8
Statement 5.9
Statement 6.1
Statement 6.2
Statement 6.3
Statement 6.4
Statement 6.5
GPI
Statement Implementation Learning Collaborative Centres (SILCC)
Case studies
Why are Case Studies Important ?
Follow Us
